US Patent Issued to Regents of the University of Minnesota on Feb. 24 for "Next generation remdesivir antivirals" (Minnesota Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,364, issued on Feb. 24, was assigned to Regents of the University of Minnesota (Minneapolis).

"Next generation remdesivir antivirals" was invented by Courtney C. Aldrich (Minneapolis), Subhankar Panda (St. Paul, Minn.) and Tej Poudel (Minneapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compounds of the formula (I) and (II), pharmaceutical compositions comprising one or more such compounds, and methods for treating pulmonary infections with one or more such compounds (e.g., treating SARS-COV, MERS-COV or SARS-COV-2)."

The patent was filed on Jan. 19, 2022, under Application No. 17/579,271.

*For further information, ...